We have developed iBioLaunch™ technology, a unique platform for the accelerated development and manufacture of high value proteins of immediate interest as product candidates. Advantages of our technology include its speed and applicability to a broad range of disease agents. This enables us to target rapidly evolving disease agents and develop products with high safety, potency and efficacy. While all targets listed are not being pursued as product candidates, the table below summarizes the breadth of applicability of the iBioLaunch™ technology.